Schizophrenia 5 - Clinical (3)

[P511] Efficacy of KarXT on Negative Symptoms in Acute Schizophrenia: An Analysis of Pooled Data from 3 Trials

*Scott Vuocolo¹, William P Horan¹, Amy Claxton ¹, Steven D Targum², Inder Kaul¹, Sharon Sawchak ¹, Andrew C Miller ¹, Steven M Paul¹, Stephen K Brannan ¹ (1. Karuna Therapeutics, Boston, MA, USA , 2. Signant Health, Boston, MA, USA)

Keywords:KarXT, Muscarinic receptors , Negative Symptoms, Schizophrenia , xanomeline